EDGAR Filing Documents for 0001213900-21-046254

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001213900-21-046254

Filing Date

2021-09-02

Accepted

2021-09-02 06:34:33

Documents

117

Period of Report

2021-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	ANNUAL REPORT	f20f2021_alteritytherap.htm iXBRL	20-F	2362901
2	LIST OF SUBSIDIARIES OF THE REGISTRANT	f20f2021ex8-1_alteritythe.htm	EX-8.1	1350
3	CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) UNDER THE SE	f20f2021ex12-1_alteritythe.htm	EX-12.1	8143
4	CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) UNDER THE SE	f20f2021ex12-2_alteritythe.htm	EX-12.2	8009
5	CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS	f20f2021ex13-1_alteritythe.htm	EX-13.1	3967
6	CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS	f20f2021ex13-2_alteritythe.htm	EX-13.2	3968
7	CONSENT OF PRICEWATERHOUSECOOPERS	f20f2021ex15-1_alteritythe.htm	EX-15.1	2155
8	AUDITOR'S INDEPENDENCE DECLARATION	f20f2021ex15-2_alteritythe.htm	EX-15.2	653
14	GRAPHIC	fin_001.jpg	GRAPHIC	5233
	Complete submission text file	0001213900-21-046254.txt		10416109

Data Files

Seq	Description	Document	Type	Size
9	XBRL SCHEMA FILE	athe-20210630.xsd	EX-101.SCH	151200
10	XBRL CALCULATION FILE	athe-20210630_cal.xml	EX-101.CAL	24040
11	XBRL DEFINITION FILE	athe-20210630_def.xml	EX-101.DEF	381271
12	XBRL LABEL FILE	athe-20210630_lab.xml	EX-101.LAB	771408
13	XBRL PRESENTATION FILE	athe-20210630_pre.xml	EX-101.PRE	396098
15	EXTRACTED XBRL INSTANCE DOCUMENT	f20f2021_alteritytherap_htm.xml	XML	1983363

Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000

Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906

ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)